| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/01/2008 | US7393641 Using carcinoembryonic antigen sequence specific primer from tumor site to monitor tumor preferential gene expression in cells/tissues distant from site of tumor manifestation |
| 07/01/2008 | US7393640 Terminal-phosphate-labeled nucleotides with new linkers |
| 07/01/2008 | US7393639 Methods for identifying genes and promoters of interest using the Impala transposon |
| 07/01/2008 | US7393638 Assay system and methods for detecting SARS-CV |
| 07/01/2008 | US7393637 Methods for detecting cancer and monitoring cancer progression |
| 07/01/2008 | US7393636 Method for forming self-assembly substance using oligonucleotide synthesized by gene amplification reaction, self-assembly substance and method for detecting gene |
| 07/01/2008 | US7393635 Cloning double-stranded target DNA into a double stranded vector DNA without the use restriction enzymes or any joining enzyme such as ligase |
| 07/01/2008 | US7393634 Identifying individual as having increased risk of accelerated human immunodeficiency virus by detecting presence of haplotype pairs |
| 07/01/2008 | US7393633 Detecting biotin-containing amplified DNA using biochips; prevention and treatment of cervical cancer |
| 07/01/2008 | US7393632 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 07/01/2008 | US7393631 From contaminated sample using sodium chloride solution to prevent irreversible binding to hydroxyapatite; eluting and washing; reduces empty capsids and impurities |
| 07/01/2008 | US7393630 Immunological adjuvants and antigen entrapment; combining a submicron oil-in-water emulsion with a selected antigen entrapped in, or adsorbed to, a biodegradable microparticle, wherein the microparticle is formed from a poly(L-lactide), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) |
| 07/01/2008 | US7393629 Via natural locomotion after alignment; use in biopsies |
| 07/01/2008 | US7393549 Defructosylation method |
| 07/01/2008 | US7393540 Therapeutic peptide for prevention of microorganismal infections; enzyme inhibitors; RNA inteference; antisense agents |
| 07/01/2008 | US7393539 Therapeutic agent for prevention and treatment of bacterial infection; bactericides; genetic vaccines; immunotherapy |
| 07/01/2008 | US7393448 Method of binding a compound to a sensor surface |
| 07/01/2008 | US7393318 Methods and compositions for interaction trap assays |
| 06/28/2008 | CA2612505A1 High throughput genome specific molecular markers for erucic acid content genes in brassica napus (l.) |
| 06/26/2008 | WO2008077095A2 Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of a subject |
| 06/26/2008 | WO2008076994A2 METHODS FOR DETECTION AND MEASUREMENT OF SECRETORY PHOSPHOLIPASE A2 LEVELS (sPLA2) IN BIOLOGICAL FLUIDS |
| 06/26/2008 | WO2008076948A1 Methods and compositions for the detection of a nucleic acid by a cleavage reaction |
| 06/26/2008 | WO2008076449A2 Predicting a response to olanzapine |
| 06/26/2008 | WO2008076434A2 Predicting a response to risperidone |
| 06/26/2008 | WO2008076414A2 Self-replicating materials |
| 06/26/2008 | WO2008076382A2 Bacteriophage particle agglutination |
| 06/26/2008 | WO2008076375A2 Concurrent analysis of multiple patient samples using solid phase addressable multiplex test with high signal-to-noise ratio |
| 06/26/2008 | WO2008076374A2 Devices and methods of anonymously deconvoluting combined patient samples and combined patient assays |
| 06/26/2008 | WO2008076077A1 Method of early diagnosis of epstein-barr virus-related cancer and respective reagents and kits |
| 06/26/2008 | WO2008075871A1 Peptide nucleic acid oligomers comprising universal bases, preparation methods thereof, and kits, devices and methods for the analysis, detection or modulation of nucleic acids using the same |
| 06/26/2008 | WO2008075790A2 Method for detecting cancer with nucleic acids in blood |
| 06/26/2008 | WO2008075718A1 Fluorescent molecule |
| 06/26/2008 | WO2008075713A1 Marker for diagnosis of cancer, and target molecule for therapy |
| 06/26/2008 | WO2008075520A1 Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium by using the primer or probe |
| 06/26/2008 | WO2008075519A1 Method of amplifying nucleic acid and method of analyzing nucleic acid by using the same |
| 06/26/2008 | WO2008075501A1 Rotary extraction container, method of identifying cell species and method of detecting gene using the same, and automatic nucleic acid extractor |
| 06/26/2008 | WO2008075455A1 METHOD FOR STABILIZING α-THROMBIN IN THROMBIN-CONTAINING SOLUTION |
| 06/26/2008 | WO2008075363A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | WO2008075214A1 Enzyme detection techniques |
| 06/26/2008 | WO2008075171A1 A method based on a breath test for the detection of pathogen microorganisms |
| 06/26/2008 | WO2008075072A2 Formulation |
| 06/26/2008 | WO2008074924A2 Screening method |
| 06/26/2008 | WO2008074909A1 Method of identification of species of the penaeoidea superfamily by means of dna analysis |
| 06/26/2008 | WO2008074595A1 Method for the molecular characterization of graying and pigmented hair |
| 06/26/2008 | WO2008074425A1 New high-throughput assay for identifying kinase inhibitors |
| 06/26/2008 | WO2008074330A1 Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an antiinflammatory and/or anticoagulatory agent |
| 06/26/2008 | WO2008074328A2 Microrna target site blocking oligos and uses thereof |
| 06/26/2008 | WO2008074182A1 Method for the detection and typing of human papillomavirus, and the reagent kit thereof |
| 06/26/2008 | WO2008074131A1 Skin and salivary tests for the detection of sensitivity to oxidative stress based therapies |
| 06/26/2008 | WO2008074100A1 Bioluminescent assays utilising secreted luciferases |
| 06/26/2008 | WO2008074069A1 Sheep pigmentation |
| 06/26/2008 | WO2008054595A9 Drug controlled molecular tags |
| 06/26/2008 | WO2008051530A9 Polymerase enzymes and reagents for enhanced nucleic acid sequencing |
| 06/26/2008 | WO2008046602A3 2'-terminator related pyrophosphorolysis activated polymerization |
| 06/26/2008 | WO2008039357A9 Uncoupling of dna insert propagation and expression of protein for phage display |
| 06/26/2008 | WO2008033992A3 High throughput screening assay for histone modifying enzyme modulators |
| 06/26/2008 | WO2008029140A3 Analyte detection |
| 06/26/2008 | WO2008017038A3 Methods for selecting medications |
| 06/26/2008 | WO2007146802A3 System and compositions for isolating suppressors of hiv-1 protease |
| 06/26/2008 | WO2007143317A3 Compounds and methods for modulating expression of crp |
| 06/26/2008 | WO2007143316A3 Compounds and methods for modulating expression of sglt2 |
| 06/26/2008 | WO2007127461A3 Composition and methods for the detection of cripto-3 |
| 06/26/2008 | WO2007123896A3 Mutated acvr1 for diagnosis and treatment of fibrodyplasia ossificans progressiva (fop) |
| 06/26/2008 | WO2007106203A3 Systems and methods for sanitizing egg processing equipment |
| 06/26/2008 | WO2007094854A3 Rna virus vaccines and methods |
| 06/26/2008 | WO2007076057A3 Polymerases for nucleotide analogue incorporation |
| 06/26/2008 | WO2007075988A3 Non-invasive detection of fish viruses by real-time pcr |
| 06/26/2008 | WO2007075924A9 Methods and applications of molecular beacon imaging for infectious disease and cancer detection |
| 06/26/2008 | WO2007056177A9 T315a and f317i mutations of bcr-abl kinase domain |
| 06/26/2008 | WO2006040376A3 Solution for the indefinite maintenance of nucleic acids in the cell of origin thereof |
| 06/26/2008 | WO2006026570A8 Use of stem cells to generate inner ear cells |
| 06/26/2008 | US20080155716 Serine hydroxymethyltransferase as target for herbicides |
| 06/26/2008 | US20080155712 Means for identifying nucleotide sequences involved in apomixis |
| 06/26/2008 | US20080155704 BiP is a human molecular chaperone known variously as binding immunoglobulin protein (BiP) or glucose regulated protein (Grp)78 that has antiinflammatory effect; used to monitor the therapeutic effect of BiP; markers in a blood sample may indicate that a subject is responsive to BiP |
| 06/26/2008 | US20080155703 Identifying new immunomodulatory chemical entities (NICE); reacting a candidate NICE with a Tat SH3 binding domain, identifying the bound candidate NICE and determining whether it induces monocytes to differentiate into dendritic cells (DC) or regulatory macrophages (AReg); drug screening; immunotherapy |
| 06/26/2008 | US20080154517 Method, system and computer program product for providing a dna str profile |
| 06/26/2008 | US20080154512 Systems and methods for baselining and real-time pcr data analysis |
| 06/26/2008 | US20080154027 nucleotide sequences comprising a Yarrowia genetic translation initiation site, for encoding desaturases |
| 06/26/2008 | US20080153926 Methods and compositions for modulating mitochondrial alderhyde dehydrogenase-2 |
| 06/26/2008 | US20080153877 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 06/26/2008 | US20080153797 Identifying compounds that can treat autoimmune conditions; ulcerative colitis, inflammatory bowel disease, Crohn's disease, psoriasis, actinic keratosis, arthritis, multiple sclerosis, optic neuritis |
| 06/26/2008 | US20080153792 Drug Identification and Treatment Method |
| 06/26/2008 | US20080153769 A nucleic acid ligand whose sequence optionally includes a 2'-O-methyl modification and/or a 2'-O-fluoro modification, useful for inhibiting coagulation in a host undergoing a therapeutic regime such as surgery or coronary artery bypass |
| 06/26/2008 | US20080153767 Modulation of forkhead box o1a expression |
| 06/26/2008 | US20080153764 Used in cells and transgenic animals for a variety of applications including producing and studying the effects of RNAi and microRNA mediated gene silencing. |
| 06/26/2008 | US20080153737 Method of Delivering Rna Interference and Uses Thereof |
| 06/26/2008 | US20080153715 Apparatus and Method for Detecting Genetic Mutations and Single Nucleotide Polymorphisms |
| 06/26/2008 | US20080153148 Increasing bioavailability of carotenoids |
| 06/26/2008 | US20080153146 For contacting immobilized cell, hydrodynamic low pressure is generated acting on cell membrane through contact tip projecting into opening; possibile to select individual cell from suspension according to one criterion, i.e. cell parameter, and position and immobilize selected cell on measurement site |
| 06/26/2008 | US20080153126 Mutant Aox1 Promoters |
| 06/26/2008 | US20080153125 use of a filter material having a surface adapted to receive water sample in order to retain all microbes from the sample on filter surface under conditions that minimize the potential for contamination from other sources, and permits filter surface to be incubated to grow viable microbes |
| 06/26/2008 | US20080153124 Methods for improving the function of heterlogous G protein-coupled receptors |
| 06/26/2008 | US20080153123 METHOD FOR DETECTION OF cAMP AND cGMP |
| 06/26/2008 | US20080153122 Method and system for enhancing self-treatment of onychomycosis |
| 06/26/2008 | US20080153121 Chemical Sensor Enhanced by Direct Coupling of Redox Enzyme to Conductive Surface |
| 06/26/2008 | US20080153120 Salt Taste Receptor and its Use in an Assay for Salt Taste |
| 06/26/2008 | US20080153119 Detecting the presence of pyruvate kinase isoenzyme in feces |
| 06/26/2008 | US20080153118 test values for glucose and for an endogenous reference substance (pyruvate or lactate) are detected in a sample liquid obtained from a body tissue by microdialysis, microperfusion or ultrafiltration and the test value for glucose is corrected in accordance with the test value for reference substance |
| 06/26/2008 | US20080153117 denaturing the protein in such test set with guanidine thiocyanate or one or more chaotropic agents so as to enhance antibody reactivity towards aberrant protein while antibody reactivity towards a normal form of the protein is reduced or unchanged; reducing the risk of scoring a false-positive test |